Capnia is a startup based in the United States. Brouky records 2 investors associated with the company.
Capnia develops the CoSense® ETCOc Monitor, a non-invasive diagnostic device that measures end-tidal carbon monoxide in newborns' breath to detect and monitor hemolysis for improved jaundice management and reduced risk of bilirubin neurotoxicity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.